NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $357,000 | -59.4% | 66,185 | +1.6% | 0.00% | -60.0% |
| Q4 2021 | $880,000 | -23.3% | 65,132 | +1.9% | 0.01% | -28.6% |
| Q3 2021 | $1,148,000 | +8.3% | 63,912 | +3.5% | 0.01% | +16.7% |
| Q2 2021 | $1,060,000 | -16.6% | 61,753 | -2.8% | 0.01% | -25.0% |
| Q1 2021 | $1,271,000 | +17.4% | 63,553 | -0.3% | 0.01% | +14.3% |
| Q4 2020 | $1,083,000 | +2.8% | 63,713 | +0.3% | 0.01% | -12.5% |
| Q3 2020 | $1,054,000 | -28.4% | 63,553 | -0.1% | 0.01% | -33.3% |
| Q2 2020 | $1,473,000 | +19.1% | 63,613 | -8.2% | 0.01% | +9.1% |
| Q1 2020 | $1,237,000 | +41.5% | 69,293 | +71.1% | 0.01% | +57.1% |
| Q4 2019 | $874,000 | +19.6% | 40,503 | +0.9% | 0.01% | 0.0% |
| Q3 2019 | $731,000 | -84.6% | 40,153 | -70.0% | 0.01% | -75.9% |
| Q2 2019 | $4,760,000 | +23.5% | 133,794 | +16.6% | 0.03% | +16.0% |
| Q1 2019 | $3,854,000 | +2.0% | 114,704 | -0.3% | 0.02% | -10.7% |
| Q4 2018 | $3,780,000 | -45.4% | 115,005 | +1.2% | 0.03% | -36.4% |
| Q3 2018 | $6,925,000 | +303.1% | 113,603 | +223.0% | 0.04% | +144.4% |
| Q2 2018 | $1,718,000 | – | 35,176 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |